Orthofix Medical (NASDAQ:OFIX) Stock: Insider Juniper Investment Company, Ll Buys 14,803 Shares

Orthofix Medical Inc. (NASDAQ:OFIX) major shareholder Juniper Investment Company, Ll bought 14,803 shares of Orthofix Medical stock in a transaction dated Wednesday, November 11th. The shares were bought at an average cost of $7.04 per share, with a total value of $104,213.12. Following the completion of the acquisition, the insider owned 4,461,019 shares of the company’s stock, valued at $31,405,573.76. The trade was a 0.33% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Juniper Investment Company, Ll also recently made the following trade(s):

• On Monday, November 9th, Juniper Investment Company, Ll purchased 675,000 shares of Orthofix Medical stock. The stock was bought at an average price of $7.41 per share, with a total value of $5,001,750.00.

Orthofix Medical Trading Up 3.3%

OFIX traded up $0.23 during trading on Friday, reaching $7.17. The company had a trading volume of 553,153 shares, compared to its average volume of 661,289. The firm’s 50-day simple moving average is $9.07 and its 200 day simple moving average is $10.83. The company has a market cap of $292.03 million, a price-to-earnings ratio of -6.40 and a beta of 0.66. Orthofix Medical Inc. has a 12-month low of $6.52 and a 12-month high of $16.42. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.67 and a current ratio of 3.11.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings data on Monday, November 9th. The medical device company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.11. Orthofix Medical had a negative return on equity of 10.32% and a negative net margin of 5.39%. The firm had revenue of $207.86 million for the quarter, compared to the consensus estimate of $210.52 million. Equities research analysts anticipate that Orthofix Medical Inc. will post -1.29 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of OFIX. Moore Capital Management LP acquired a new position in shares of Orthofix Medical in the 2nd quarter valued at about $781,000. Paradigm Capital Management Inc. NY purchased a new stake in shares of Orthofix Medical in the second quarter worth approximately $30,167,000. BlackRock Inc. acquired a new stake in shares of Orthofix Medical during the second quarter worth approximately $30,405,000. Engine Capital Management LP boosted its holdings in shares of Orthofix Medical by 3.2% during the first quarter. Engine Capital Management LP now owns 4,390,779 shares of the medical device company’s stock worth $50,362,000 after purchasing an additional 137,858 shares during the period. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Orthofix Medical during the second quarter worth approximately $1,089,000. 89.76% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OFIX has been the subject of several research analyst reports. TD Cowen restated a “hold” rating and issued a $9.00 price target on shares of Orthofix Medical in a research report on Tuesday. Canaccord Genuity Group decreased their price objective on shares of Orthofix Medical from $18.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, August 10th. Finally, Weiss Ratings cut shares of Orthofix Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, November 3rd. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Orthofix Medical has an average rating of “Hold” and an average price target of $13.50.

Orthofix Medical Company Profile

Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.